Xiaokun Xiao - Concepedia

Author

Xiaokun Xiao

Ionis Pharmaceuticals (United States)

Also Known As

Xiaokun Xiao

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Ionis Pharmaceuticals (United States)Shanghai Jiao Tong University Memorial Sloan Kettering Cancer Center The University of Texas MD Anderson Cancer Center

About

Xiaokun Xiao is an author at Ionis Pharmaceuticals (United States) specializing in tumor microenvironment, cell biology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	291
2	Engineering	2	2	98
3	Natural Sciences	1	1	44
4	Allergy	1	1	126
5	Biomolecular Engineering	1	1	44

Xiaokun Xiao

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
The lncRNA Malat1 Is Dispensable for Mouse Development but Its Transcription Plays a cis-Regulatory Role in the Adult Bin Zhang, Gayatri Arun, Yuntao S. Mao, Cell Reports	2012	604
AZD9150, a next-generation antisense oligonucleotide inhibitor of <i>STAT3</i> with early evidence of clinical activity in lymphoma and lung cancer David S. Hong, Razelle Kurzrock, Youngsoo Kim, Science Translational Medicine	2015	428
STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial Matthew J. Reilley, Patricia McCoon, Carl Cook, Journal for ImmunoTherapy of Cancer	2018	275
Characterization of Target mRNA Reduction Through <i>In Situ</i> RNA Hybridization in Multiple Organ Systems Following Systemic Antisense Treatment in Animals Gene Hung, Xiaokun Xiao, Raechel Peralta, Nucleic Acid Therapeutics ImmunologyAntisense Oligonucleotide DrugsAntisense TherapyNovel TherapyTarget Mrna Reduction	2013	126
Selective Down-Regulation of Glioma-Associated Oncogene 2 Inhibits the Proliferation of Hepatocellular Carcinoma Cells Youngsoo Kim, Joon Won Yoon, Xiaokun Xiao, Cancer Research Hepatocellular Carcinoma CellsCell DeathPathologyGlioma-associated Oncogene 2Cancer Biology	2007	121
Enhanced Potency of GalNAc-Conjugated Antisense Oligonucleotides in Hepatocellular Cancer Models Youngsoo Kim, Minji Jo, Joanna Schmidt, Molecular Therapy	2019	72
Energy evaluation of optimal control strategies for central VWV chiller systems Xinqiao Jin, Zhimin Du, Xiaokun Xiao Applied Thermal Engineering Distributed Energy SystemElectrical EngineeringEngineeringEnergy AnalysisSmart Grid	2006	68
Use of a Chemically Modified Antisense Oligonucleotide Library to Identify and Validate Eg5 (Kinesin-Like 1) as a Target for Antineoplastic Drug Development Erich Koller, Stephanie Propp, Hong Zhang, Cancer Research Chemoprevention StrategyMolecular BiologyCell DeathTumor BiologyMedicinal Chemistry	2006	44
Prediction-based online optimal control of outdoor air of multi-zone VAV air conditioning systems Xinqiao Jin, Ren Haigang, Xiaokun Xiao Energy and Buildings Energy ControlOutdoor AirEngineeringAerospace EngineeringEnergy Management	2005	30
The Distinct and Cooperative Roles of Toll-Like Receptor 9 and Receptor for Advanced Glycation End Products in Modulating <i>In Vivo</i> Inflammatory Responses to Select CpG and Non-CpG Oligonucleotides Suzanne Paz, Jill Hsiao, Patrick Cauntay, Nucleic Acid Therapeutics	2017	28

Page 1